Ann: FY20 Results Presentation, page-48

most interesting part of this annual report is that is allows one to see what is happening, financially, in that last few months; the report is much better (accelerated in profitability) than one could expect; so, if buyers were gobbling at 45 cents before the report and the report is better than could be expected, then who would be a seller now; is it a classic "buy the rumour sell the news"

I honestly do not get it; but that does not matter; what I do get is AT1 is still a baby day trader stock; I hope holders will ignore the daily bump and grind; there is no need to participate in the daily guff; one only needs to focus on the story: the story is a product that has a big market and is profitable

From reading many comments here it is distressing some people still think Atomo is a bio or a big pharma or a covid only or even a current antigen tester. If you are day trading on a chart that is fine. If you are investing in a company you would like to own for more than 5 minutes, then best to know about the company. The IPO (and the shares being available) were for the company to grow profitably. They are delivering as far as I can see.